Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 57 for “"Relapsing-Remitting multiple sclerosis"”.

  1. Fixel based analysis of relapsing remitting multiple sclerosis subjects

    … tool in the diagnosis and monitoring of multiple sclerosis (MS). Diffusion MRI can be used to probe changes in normal appearing white matter (NAWM) through its ability to image changes in water diffusivity. Standard diffusion imaging techniques such as diffusion tensor imaging (DTI) are …

    ubc Repository record for Fixel based analysis of relapsing remitting multiple sclerosis subjects (opens in a new tab) Download PDF for Fixel based analysis of relapsing remitting multiple sclerosis subjects (opens in a new tab)

  2. CONTRIBUTING FACTORS TO RESILIENCE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS

    … self-reliance, equanimity and meaningfulness) in multiple sclerosis (MS). The sample consisted of 152 individuals diagnosed with relapsing-remitting MS who were either attending a neurology clinic, members of the National MS Society or members of a support group in the Northern Virginia, …

    maryland Repository record for CONTRIBUTING FACTORS TO RESILIENCE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (opens in a new tab)

  3. Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies

    Multiple sclerosis is a demyelinating disease affecting the central nervous system. It is the most prevalent disabling neurological condition among young adults, with onset typically between 20 and 40 years of age. Infiltrating immune cells and microglia activations are associated with inflammatory …

    bu Repository record for Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies (opens in a new tab)

  4. Comparison of first-line therapies for relapsing-remitting multiple sclerosis

    Multiple Sclerosis (MS) is a chronic and potentially disabling disease of the central nervous system (CNS) in which the immune system attacks the protective myelin layer that surrounds nerve cells. While the majority of individuals diagnosed with MS initially present with a non-progressive …

    bu Repository record for Comparison of first-line therapies for relapsing-remitting multiple sclerosis (opens in a new tab)

  5. The experience of young adults living with relapsing-remitting multiple sclerosis

    … the experience of young adults living with relapsing-remitting multiple sclerosis (RRMS) who were diagnosed by a physician at least six months prior to the study. This study was important because, prior to this proposed study, there has been limited work focused specifically on interpreting …

    missouri Repository record for The experience of young adults living with relapsing-remitting multiple sclerosis (opens in a new tab)

  6. PREGNANCY, NEONATAL AND DISEASE OUTCOMES IN WOMEN WITH RELAPSING REMITTING MULTIPLE SCLEROSIS

    … neonatal and disease outcomes in women with Relapsing Remitting Multiple Sclerosis (RRMS) exposed to different therapeutic agents— natalizumab (Tysabri®) and Vitamin D. Methods Data from German and Canadian Multiple Sclerosis (MS) pregnancy registries was compared to evaluate neonatal and …

    toronto-retro Repository record for PREGNANCY, NEONATAL AND DISEASE OUTCOMES IN WOMEN WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (opens in a new tab)

  7. The effect of relapsing-remitting Multiple Sclerosis on gait variability and regularity

    Multiple Sclerosis (MS) is an inflammatory and neurodegenerative autoimmune disease that destroys the myelin sheath of the central nervous system. Gait impairments are one of the most debilitating and concerning symptoms for PwMS that can significantly impact an individual’s quality of life. Gait …

    regina Repository record for The effect of relapsing-remitting Multiple Sclerosis on gait variability and regularity (opens in a new tab) Download PDF for The effect of relapsing-remitting Multiple Sclerosis on gait variability and regularity (opens in a new tab)

  8. Models for two-state disease processes with applications to relapsing-remitting multiple sclerosis

    In diseases like relapsing-remitting multiple sclerosis (MS), patients experience repeated transitions between symptom-free and symptomatic disease states (the symptomatic state is called an exacerbation). Analyses for this kind of data commonly ignore the information available on the second state …

    ubc Repository record for Models for two-state disease processes with applications to relapsing-remitting multiple sclerosis (opens in a new tab) Download PDF for Models for two-state disease processes with applications to relapsing-remitting multiple sclerosis (opens in a new tab)

  9. Oral Pharmacotherapy for Relapsing-Remitting Multiple Sclerosis: Systematic Review and Indirect Treatment Comparison

    … pharmacotherapy has the potential to offer multiple sclerosis patients improved clinical outcomes compared to traditional therapies.</p> <p><strong><em>Objectives </em></strong></p> <p>This review assesses the effects of oral therapies compared to placebo and interferon beta-1a in adults …

    mcmaster Repository record for Oral Pharmacotherapy for Relapsing-Remitting Multiple Sclerosis: Systematic Review and Indirect Treatment Comparison (opens in a new tab)

  10. Fatigue and salivary cortisol in relapsing-remitting multiple sclerosis: an investigation in everyday life

    Multiple sclerosis (MS) is a chronic autoimmune disease characterised by inflammatory attacks on the central nervous system. Fatigue is a common symptom in MS, yet its aetiology, exacerbating factors, and manifestation in everyday life are unclear. Given its role in regulating inflammation, energy …

    soton Download PDF for Fatigue and salivary cortisol in relapsing-remitting multiple sclerosis: an investigation in everyday life (opens in a new tab)

  11. Dysregulated B Cells in Relapsing Remitting Multiple Sclerosis and Their Impact on T-Cell Function

    Relapsing-remitting multiple sclerosis (MS) is an autoimmune mediated inflammatory demyelinating disorder of the central nervous system. The role of B cells in the pathoetiology of MS is substantiated by cell depletion therapies but is not well understood. We hypothesized that B cells from MS …

    utswmed Repository record for Dysregulated B Cells in Relapsing Remitting Multiple Sclerosis and Their Impact on T-Cell Function (opens in a new tab)

  12. Magnetic resonance imaging lesion count as a surrogate endpoint in relapsing-remitting multiple sclerosis clinical trials

    … endpoint in phase 2 clinical trials for relapsing-remitting multiple sclerosis (RRMS) patients. However, this surrogacy relationship has not been completely validated. In this report, we study whether at the trial level, the MRI lesion count is a good surrogate endpoint for the relapse …

    ubc Repository record for Magnetic resonance imaging lesion count as a surrogate endpoint in relapsing-remitting multiple sclerosis clinical trials (opens in a new tab) Download PDF for Magnetic resonance imaging lesion count as a surrogate endpoint in relapsing-remitting multiple sclerosis clinical trials (opens in a new tab)

  13. Impact of symptoms on quality of life in women with relapsing-remitting multiple sclerosis and healthy women

    Persons with multiple sclerosis (MS) experience a number of symptoms. The purpose of this study was to examine pain, fatigue, depression, sleep disturbance, and quality of life in women with RRMS and healthy women. Women with RRMS had more prevalent pain (p = .005), average pain intensity (p = …

    missouri Repository record for Impact of symptoms on quality of life in women with relapsing-remitting multiple sclerosis and healthy women (opens in a new tab)

  14. Cost-Utility Analysis of Medications for Relapsing-Remitting Multiple Sclerosis: A United States Third-Party Payer Perspective

    … therapies (DMTs) have recently been approved for relapsing-remitting multiple sclerosis (RRMS) in the United States. Objective: To assess the values of 10 first-line therapies for RRMS, including generic glatiramer acetate, versus the natural history of disease for a newly diagnosed RRMS patient. …

    washington Repository record for Cost-Utility Analysis of Medications for Relapsing-Remitting Multiple Sclerosis: A United States Third-Party Payer Perspective (opens in a new tab)

  15. Balancing the demands of two tasks: an investigation of cognitive-motor dual-tasking in relapsing remitting multiple sclerosis

    Background: People with relapsing remitting MS (PwRRMS) suffer disproportionate decrements in gait under dual-task conditions, when walking and a cognitive task are combined. There has been much less investigation of the impact of cognitive demands on balance. This study investigated whether: (1) …

    glasgow Download PDF for Balancing the demands of two tasks: an investigation of cognitive-motor dual-tasking in relapsing remitting multiple sclerosis (opens in a new tab)

  16. An investigation of cognitive impairments in Relapsing Remitting Multiple Sclerosis using an ecologically valid test of executive functioning

    Background<br/>Multiple Sclerosis (MS) is a multi-faceted condition which is characterised primarily by demyelination of white matter in the central nervous system. MS is associated with physical, cognitive and emotional impairments, which can have a significant impact on daily functioning. …

    kings Repository record for An investigation of cognitive impairments in Relapsing Remitting Multiple Sclerosis using an ecologically valid test of executive functioning (opens in a new tab) Download PDF for An investigation of cognitive impairments in Relapsing Remitting Multiple Sclerosis using an ecologically valid test of executive functioning (opens in a new tab)

Page 1 of 3